Article
Comprehensive analysis of germline drivers in endometrial cancer.
Journal of the National Cancer Institute - 8 May 2023
Gordhandas Sushmita, Rios-Doria Eric, Cadoo Karen A, Catchings Amanda, Maio Anna, Kemel Yelena, Sheehan Margaret, Ranganathan Megha, Green Dina, Aryamvally Anjali, Arnold Angela G, Salo-Mullen Erin, Manning-Geist Beryl, Sia Tiffany, Selenica Pier, Da Cruz Paula Arnaud, Vanderbilt Chad, Misyura Maksym, Leitao Mario M, Mueller Jennifer J, Makker Vicky, Rubinstein Maria, Friedman Claire F, Zhou Qin, Iasonos Alexia, Latham Alicia, Carlo Maria I, Murciano-Goroff Yonina R, Will Marie, Walsh Michael F, Issa Bhaloo Shirin, Ellenson Lora H, Ceyhan-Birsoy Ozge, Berger Michael F, Robson Mark E, Abu-Rustum Nadeem, Aghajanian Carol, Offit Kenneth, Stadler Zsofia, Weigelt Britta, Mandelker Diana L, Liu Ying L
Abstract excerpt
BACKGROUND: We sought to determine the prevalence of germline pathogenic variants (gPVs) in unselected patients with endometrial cancer (EC), define biallelic gPVs within tumors, and describe their associations with clinicopathologic features. METHODS: Germline assessment of at least 76 cancer predisposition genes was performed in patients with EC undergoing clinical tumor-normal Memorial Sloan...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
